Compare profiles
Side-by-side leveling, scope, and market pay. Add up to four via ?keys=SWE.GEN.P5,SWE.GEN.P6.
| vs | P5 PHARMA.PHARMACOA353.P5 Pharmacovigilance (Drug Safety) — P5 | P4 PHARMA.PHARMACOA353.P4 Pharmacovigilance (Drug Safety) — P4 | P6 PHARMA.PHARMACOA353.P6 Pharmacovigilance (Drug Safety) — P6 | P3 PHARMA.PHARMACOA353.P3 Pharmacovigilance (Drug Safety) — P3 |
|---|---|---|---|---|
| Market pay | $112k ($88k–$143k)inherited | $89k ($70k–$113k)inherited | $153k ($120k–$195k)inherited | $67k ($53k–$85k)inherited |
| Level | P5 · P5 — Expert Professional | P4 · P4 — Senior Professional | P6 · P6 — Principal Professional | P3 · P3 — Mid-Level Professional |
| Function | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) |
| Focus | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) | Pharmacovigilance (Drug Safety) |
| Typical years | 8–12 | 5–8 | 12–18 | 3–5 |
| Scope | Multiple systems or a technical domain | A system or set of related features | Organization-wide architecture and the hardest problems | Features or a sub-system end-to-end |
| Autonomy | Sets direction within the domain | Self-directed; reviewed at critical decision points | Defines direction; minimal oversight | Works independently on standard work; reviewed on the non-standard |
| Impact | Org / multi-team outcomes | Multi-team / function outcomes | Organization-wide | Project / team outcomes |
| Decision rights | Authority over a technical domain | Owns technical decisions for a system; influences adjacent design | Sets technical strategy for a major area | Owns implementation decisions for own scope |